EZH2 staining using a ≥80% positivity threshold was 100% specific for thymic carcinoma versus type A thymoma and MNTLS but was not useful for the distinction of thymic carcinoma from type B3 thymoma. The gene discussed is EZH2; the disease is thymic carcinoma.